Ballast Advisors’s Eli Lilly LLY Stock Holding History

Ballast Advisors’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$416K	Sell	452 -2	-0.4%	-$2.03K	0.12%	77
2025 Q4	$488K	Sell	454 -20	-4%	-$19.1K	0.13%	72
2025 Q3	$362K	Buy	474 +22	+5%	+$16.4K	0.1%	81
2025 Q2	$352K	Sell	452 -2	-0.4%	-$1.55K	0.1%	81
2025 Q1	$375K	Hold	454	–	–	0.12%	81
2024 Q4	$350K	Buy	454 +2	+0.4%	+$1.66K	0.11%	82
2024 Q3	$400K	Hold	452	–	–	0.12%	82
2024 Q2	$409K	Sell	452 -1	-0.2%	-$800	0.13%	82
2024 Q1	$352K	Buy	453 +1	+0.2%	+$712	0.12%	88
2023 Q4	$263K	Sell	452 -133	-23%	-$77.6K	0.1%	95
2023 Q3	$314K	Hold	585	–	–	0.13%	90
2023 Q2	$274K	Sell	585 -200	-25%	-$83.9K	0.1%	96
2023 Q1	$270K	Hold	785	–	–	0.11%	93
2022 Q4	$287K	Sell	785 -120	-13%	-$42.5K	0.13%	87
2022 Q3	$293K	Sell	905 -15	-2%	-$4.75K	0.14%	82
2022 Q2	$298K	Hold	920	–	–	0.13%	83
2022 Q1	$263K	Hold	920	–	–	0.1%	100
2021 Q4	$254K	Buy	+920	New	+$233K	0.1%	98

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $84.5B AUM 11.36% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Ballast Advisors's LLY Position: Q1 2026 in Review

Ballast Advisors reduced its Eli Lilly (LLY) stake by 0.44% in Q1 2026, selling an estimated $2.03K and leaving 452 shares worth $416K. The position accounts for 0.12% of the portfolio, ranked #77.

Ballast Advisors first reported a position in LLY in Q4 2021 and has held it in 18 quarters since. The position peaked at $488K in Q4 2025. 4,352 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

Ballast Advisors held 452 shares of Eli Lilly worth $416K as of Q1 2026.
Ballast Advisors sold 2 Eli Lilly shares in Q1 2026, an estimated $2.03K.
Eli Lilly made up 0.12% of Ballast Advisors's portfolio in Q1 2026, its #77 holding.
Ballast Advisors first reported a position in Eli Lilly in Q4 2021 and has held it in 18 quarters since.
Ballast Advisors's Eli Lilly position peaked at $488K in Q4 2025.
4,352 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Ballast Advisors's 13F filing for Q1 2026, filed 13 May 2026.